Relapse Prevention in Major Depressive Disorder After Successful Acute Electroconvulsive Treatment: a 6-month Double-blind Comparison of Three Fixed Dosages of Escitalopram and a Fixed Dose of Nortriptyline – Lessons from a Failed Randomised Trial of the Danish University Antidepressant Group (DUAG-7)

Depressive Disorder ◽

Relapse Prevention ◽

Randomised Trial ◽

Fixed Dose ◽

Major Depressive ◽

Double Blind ◽

Electroconvulsive Treatment ◽

A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v68n0207 ◽

2007 ◽

Vol 68 (02) ◽

pp. 224-236 ◽

Cited By ~ 133

Author(s):

Michael E. Thase ◽

Sara A. Corya ◽

Olawale Osuntokun ◽

Michael Case ◽

David B. Henley ◽

...

Keyword(s):

Depressive Disorder ◽

Treatment Resistant ◽

Major Depressive ◽

Double Blind ◽

A double-blind comparison of moclobemide and toloxatone in out-patients presenting a major depressive disorder

Psychopharmacology ◽

10.1007/bf02246253 ◽

1992 ◽

Vol 106 (S1) ◽

pp. S118-S119 ◽

Cited By ~ 3

Author(s):

P. Lemoine ◽

C. Mirabaud

Keyword(s):

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

P.2.c.024 A double-blind, randomised, placebocontrolled, relapse-prevention study with Lu AA21004 in patients with major depressive disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(11)70638-1 ◽

2011 ◽

Vol 21 ◽

pp. S396-S397

Author(s):

M. Dragheim ◽

H. Loft ◽

I. Florea ◽

J.P. Boulenger

Keyword(s):

Depressive Disorder ◽

Relapse Prevention ◽

Prevention Study ◽

Major Depressive ◽

Double Blind

P.1.207 Double-blind comparison of escitalopram and venlafaxine XR in the treatment of major depressive disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(03)91917-1 ◽

2003 ◽

Vol 13 ◽

pp. S263 ◽

Cited By ~ 5

Author(s):

R. Bielski ◽

D. Ventura ◽

C. Chang ◽

A. Korotzer

Keyword(s):

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0b013e3283542457 ◽

2012 ◽

Vol 27 (4) ◽

pp. 215-223 ◽

Cited By ~ 233

Author(s):

Cornelius Katona ◽

Thomas Hansen ◽

Christina Kurre Olsen

Keyword(s):

Depressive Disorder ◽

Elderly Patients ◽

Fixed Dose ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Study

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)79213-2 ◽

2009 ◽

Vol 2009 ◽

pp. 281-282

Author(s):

J.C. Ballenger

Keyword(s):

Depressive Disorder ◽

Fixed Dose ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Trial

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial☆

Pain ◽

10.1016/j.pain.2008.02.024 ◽

2008 ◽

Vol 136 (3) ◽

pp. 432-444 ◽

Cited By ~ 242

Author(s):

Jon I. Russell ◽

Philip J. Mease ◽

Timothy R. Smith ◽

Daniel K. Kajdasz ◽

Madelaine M. Wohlreich ◽

...

Keyword(s):

Depressive Disorder ◽

Fixed Dose ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Trial

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/j.ypsy.2010.10.061 ◽

2011 ◽

Vol 2011 ◽

pp. 250-251

Author(s):

J.C. Ballenger

Keyword(s):

Depressive Disorder ◽

Activity Cycle ◽

Anxiety Symptoms ◽

The Novel ◽

Major Depressive ◽

Double Blind ◽

Blind Comparison ◽

Rest Activity

Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/00004850-199903000-00003 ◽

1999 ◽

Vol 14 (2) ◽

pp. 73-80 ◽

Cited By ~ 68

Author(s):

J Massana ◽

H-J M??llerb ◽

G D Burrows ◽

R M Montenegro

Keyword(s):

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Randomized, double‐blind comparison of aripiprazole/sertraline combination and placebo/sertraline combination in patients with major depressive disorder

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.12663 ◽

2018 ◽

Vol 72 (8) ◽

pp. 591-601 ◽

Cited By ~ 2

Author(s):

Kunitoshi Kamijima ◽

Mahito Kimura ◽

Kazuo Kuwahara ◽

Yuri Kitayama ◽

Yoshihiro Tadori

Keyword(s):

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽